Company / Capital Expenditures
CAPRICOR THERAPEUTICS, INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$2.9M
FY2025
5-year range
$1.2M / $2.9M
FY2021-FY2025
Trend
+148.9%
vs FY2024
Sector context
#88 of 195
Health Care
What the data says
At $3M, CAPRICOR THERAPEUTICS, INC.'s capital expenditures ranks #88 of 195 in the Health Care sector. Capital Expenditures returned to growth in FY2025 after 2 years of decline, reaching $3M.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +39.6%.
Improved from $1M to $3M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +13.2%
- 5-Year CAGR
- +39.6%
- 10-Year CAGR
- -
Sector benchmark
#88 of 195 in Health CareTop 45% of 195This company $2.9M Sector average $116.9M
▼
-97.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +39.6%, indicating consistent growth.
- In FY2025, capital expenditures increased 148.9% year-over-year.
- Ranks #88 out of 195 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9M | +148.9% |
| FY2024 | $1.2M | -11.0% |
| FY2023 | $1.3M | -34.4% |
| FY2022 | $2.0M | +67.2% |
| FY2021 | $1.2M | +118.5% |
| FY2020 | $547.6K | +73.0% |
| FY2019 | $316.5K | +0.0% |
| FY2018 | $316.5K | +883.3% |
| FY2017 | $32.2K | -83.2% |
| FY2016 | $192.0K | +48.0% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026